While we only studied 2 samples (one BTZ-sensitive and one BTZ-resistant sample), our findings suggest that p21 stabilization plays a significant role in the anti-tumor activity of BTZ in B-cell lymphoma. The gene discussed is CASC3; the disease is B-cell non-Hodgkin lymphoma.